Summit Preview

CVC 2017 ReportHealth Evolution, with the support of Echo Health Ventures, GE Ventures and Humana, convened its annual Corporate Venture Group (CVG) meeting in April 2018.

Corporate venture capital (CVC) has become not just a norm in health care, but a dominant force in the financing and strategic landscape. The Health Evolution CVG is comprised of corporate venture program leaders who bring an increasingly influential external perspective to the development of their corporate parents’ strategies for growth and innovation.

The 2018 Survey and Health Evolution Summit discussions delved deeply into topics around HE-CVG member learnings, best practice approaches and challenges in driving and rewarding portfolio company-parent engagement for impact.

To understand the key shifts unfolding in health care Corporate Venture Capital today, download our report now!

Get the latest pulse check on health care Corporate Venture Capital here:

Health Evolution CVG Survey & Meeting Participants (Partial List*):
    • Ascension Ventures
    • Aetna
    • BCBS Venture Partners
    • Comcast Ventures
    • Echo Health Ventures (Cambia Health Solutions, Mosaic)
    • GE Ventures
    • GIS Strategic Ventures
    • Google Ventures
    • HCA – Health Insight Capital
    • Highmark Health
    • Humana Health Ventures
  • Kaiser Permanente Ventures
  • McKesson Ventures
  • Merck Global Health Innovation Fund
  • NewYork-Presbyterian
  • Optum Ventures
  • Providence St. Joseph Health
  • Rex Health Ventures
  • Sanofi Ventures
  • Summation Health Ventures
  • Tufts Health Plan
*The participating HE-CVG members are primarily direct minority investors in external companies run by unaffiliated entrepreneurs, although a few also are involved in founding/incubating new initiatives. Some survey participants asked that their company names not be included in any report.